Stock Track | Neogen Soars 17.35% on Strong Q1 Earnings Beat and Positive Outlook

Stock Track
Oct 09

Neogen Corp (NEOG) shares surged 17.35% in Thursday's pre-market trading session following the release of its better-than-expected first-quarter earnings report for fiscal year 2026. The food and animal safety products company demonstrated robust financial performance, surpassing analyst estimates and providing an optimistic outlook for the fiscal year.

According to the earnings release, Neogen reported Q1 revenue of $209.189 million, significantly beating the analyst consensus estimate of $204.2 million. The company's earnings per share came in at $0.17, with a net income of $36.338 million for the quarter. Adjusted figures showed an EPS of $0.04, meeting analyst expectations, and an adjusted EBITDA of $35.5 million, indicating strong operational performance despite a slight year-over-year revenue decline of 3.6%.

Looking ahead, Neogen provided an optimistic outlook for the full fiscal year 2026, projecting revenue between $820 million and $840 million, which exceeded analyst estimates. The company also expects adjusted EBITDA in the range of $165-175 million. This positive guidance, coupled with the impressive Q1 results and recently implemented cost-cutting initiatives, including a company-wide headcount reduction, appears to have bolstered investor confidence, driving the substantial pre-market stock price increase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10